XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 9,089 $ 6,617 $ 17,122 $ 16,975
General and administrative 6,013 4,832 11,473 9,852
Total operating expenses 15,102 11,449 28,595 26,827
Loss from operations (15,102) (11,449) (28,595) (26,827)
Other income (expense):        
Interest and investment income 2,556 214 4,877 269
Other expense, net (20) (15) (36) (16)
Total other income, net 2,536 199 4,841 253
Net loss $ (12,566) $ (11,250) $ (23,754) $ (26,574)
Net loss per share attributable to common shareholders - basic $ (0.45) $ (0.86) $ (0.85) $ (2.04)
Net loss per share attributable to common shareholders - diluted $ (0.45) $ (0.86) $ (0.85) $ (2.04)
Weighted-average common shares outstanding used in net loss per share - basic 28,022,306 13,016,955 27,983,597 13,016,955
Weighted-average common shares outstanding used in net loss per share - diluted 28,022,306 13,016,955 27,983,597 13,016,955